Hellman & Friedman Capital Partners X (Parallel), L.P.

Insider profile

Performance

Overall performance

Performance over holding periods
30 days 90 days 120 days
Average return -8% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
4 0% Buy
34 71% Buy
47 69% Buy
Hellman & Friedman Capital Partners X (Parallel), L.P.'s trades of Medline Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-06-01 2026-05-28 S Sale
99,364 +24.2%
117.77
US$2,459,888
99,364 +24.2% 117.77 US$2,459,888
2026-06-01 2026-05-28 S Sale
47,101 +26.8%
441.26
US$977,178
47,101 +26.8% 441.26 US$977,178
2026-06-01 2026-05-28 S Sale
34,188 -42.3%
117.91
US$4,496,766
34,188 -42.3% 117.91 US$4,496,766
2026-06-01 2026-05-28 S Sale
17,947,337 -98.7%
36.54
US$655,750,826
17,947,337 -98.7% 36.54 US$655,750,826
2026-03-12 2026-03-10 S Sale
1,060,095 -11.8%
40.51
US$42,942,328
1,060,095 -11.8% 40.51 US$42,942,328
2026-03-12 2026-03-10 S Sale
9,801,455 -11.4%
40.51
US$397,037,339
9,801,455 -11.4% 40.51 US$397,037,339
2026-03-12 2026-03-10 S Sale
629,933 -13.1%
40.51
US$25,517,326
629,933 -13.1% 40.51 US$25,517,326
2026-03-12 2026-03-10 S Sale
14,639,754 -96.3%
40.51
US$593,027,155
14,639,754 -96.3% 40.51 US$593,027,155
2025-12-22 2025-12-18 S Sale
461,760 -8.8%
28.37
US$13,099,346
461,760 -8.8% 28.37 US$13,099,346
2025-12-22 2025-12-18 S Sale
547,305 -5.6%
28.37
US$15,526,112
547,305 -5.6% 28.37 US$15,526,112
2025-12-22 2025-12-18 S Sale
5,079,306 -5.4%
28.37
US$144,091,276
5,079,306 -5.4% 28.37 US$144,091,276